# AM-101 in the Treatment of Acute Tinnitus 3

> **NCT02040194** · PHASE3 · COMPLETED · sponsor: **Auris Medical AG** · enrollment: 893 (actual)

## Conditions studied

- Tinnitus

## Interventions

- **DRUG:** AM-101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02040194
- **Lead sponsor:** Auris Medical AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2017-12-28
- **Final completion:** 2017-12-28
- **Target enrollment:** 893 (ACTUAL)
- **Last updated:** 2023-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02040194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02040194, "AM-101 in the Treatment of Acute Tinnitus 3". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02040194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*